Clinical Trials Logo
  1. Home
  2. Exacerbation Copd
  3. NCT04802096

Effects of Inspiratory Muscle Training in Addition to Pulmonary Rehabilitation in Patients With COPD Exacerbation

Exacerbation Copd Clinical Trial

Official title:
Effects of Inspiratory Muscle Training in Addition to Pulmonary Rehabilitation in Patients With COPD Exacerbation

Clinical Trial Summary

Inspiratory muscle weakness, limited functional exercise capacity and worse quality of life have been shown in patients with exacerbation of chronic obstructive pulmonary disease (COPD). Recommendations from clinical practice guideline state that promoting pulmonary rehabilitation after exacerbation can improve the conditions above. Inspiratory muscle training (IMT) has been proven to enhance inspiratory muscle strength and endurance in patient with stable COPD. However, there is less research on whether IMT in addition to pulmonary rehabilitation after exacerbation can benefit inspiratory muscle function, functional exercise capacity and quality of life in patients with COPD. The purpose of this study is to examine the effects of IMT in addition to pulmonary rehabilitation on respiratory muscle function, functional exercise capacity and quality of life in patients with exacerbation of chronic obstructive pulmonary disease.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04802096
Study type Interventional
Source National Taiwan University Hospital
Contact
Status Completed
Phase N/A
Start date March 15, 2021
Completion date September 16, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03033251 - High Flow Nasal Cannula Versus Non-Invasive Ventilation in Exacerbations of Chronic Obstructive Pulmonary Disease N/A
Completed NCT03256604 - A Sputum Screening Test to Rule-out Pneumonia at an Early Stage N/A
Terminated NCT03153826 - Determinants of Lower Limb Muscle Atrophy Induced During an Hospitalization for Exacerbation of COPD N/A
Active, not recruiting NCT03432234 - Respiratory Microbiome and COPD Exacerbations (RESMECOPD)
Recruiting NCT05704881 - Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations
Recruiting NCT04319705 - Anti-viral Effects of Azithromycin in Patients With Asthma and COPD Phase 4
Completed NCT05779384 - The COPD Attack Study
Recruiting NCT04955080 - REal-time Data Monitoring for Shared Adaptive, Multi-domain and Personalised Prediction and Decision Making for Long-term Pulmonary Care Ecosystems (RE-SAMPLE)
Completed NCT04122547 - Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis Phase 3
Completed NCT02972775 - 15-year Mortality After Hospitalization for Exacerbation of Chronic Obstructive Pulmonary Disease
Completed NCT05750810 - Exacerbations and Their Outcomes International (EXACOS International)
Completed NCT05380869 - POCT PCT in Outpatient LRTI N/A